News Archives

Statement from Bayer HealthCare on Completion of Enrollment in REMox TB

February 1, 2012

Dr. Martin Springsklee Vice President – Head Global Medical Affairs Anti-Infectives at Bayer HealthCare We started our partnership with the […]

February 1, 2012

The TB Alliance and its partners have completed patient enrollment in REMox TB, a global Phase III clinical trial, which

February 1, 2012

Prof. Charles Mgone Executive Director of the European and Developing Countries Clinical Trials Partnership (EDCTP) The enrolment of volunteers in

December 8, 2011

“The GFINDER report shows a large retraction of public funding, especially for product development partnerships (PDPs), which will have devastating

December 8, 2011

London – A fresh round of funding cuts from rich nations in the wake of the global financial crisis threaten

December 1, 2011

The meeting was convened to catalogue expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in

November 23, 2011

Almari Uys of the TB Alliance was interviewed on Lotus FM Radio in South Africa. Conradie discussed the recent collaboration

November 23, 2011

TB Alliance CEO, Dr. Mel Spigelman, was interviewed on Doctor Radio on Sirius. Those who think U.S. residents aren’t significantly

November 15, 2011

(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and

November 9, 2011

· AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign partnership to share information on TB drugs